Ann: Hydrix successfully raises $2.5M, page-2

Although no one likes cap raises, but I believe this cap raise has many positives attached to it.

• $2.5m raised via placement, which the money will go towards repaying the shareholder loan and to pay for some of the costs for AngelMed which should eventually lead to revenue north of $12m p.a.
• Both directors (Gavin Coote and Paul Wright) has further chipped in $50k each from their own pocket
• SPP seems to try reward CURRENT shareholders by having the cut of date on 1st of November 2019, which a lot of small caps don't seem to it.
• SPP is capped at $1m, which seems like the company is not desperate for money (as we anticipate for a full year of cash operating profit). Normally, the cap is extended rather than scaled back.

As bad as the dilution may be, I think it's onwards and upwards from here.